...Before HMA was acquired and integrated, CHS's weak patient volume trends lagged industry peers. However, CHS has reported a volume improvement in the last few quarters that mirrors the trend of the hospital industry....
Navigator
Enter the keyword(s) you would like to search for within this report:
Hospitals' Credit Diagnosis (Favorable Subsidy Ruling Means the ACA Is Here to Stay) – 2015/07/07 – US$ 999.00
Fitch 50 (Capital Structure Diagrams & Debt Document Summaries for Fifty of the Largest U.S. Leveraged Credits) – 2015/07/15 – US$ 999.00
Fitch 50 (Capital Structure Diagrams & Debt Document Summaries for Fifty of the Largest U.S. Leveraged Credits) -- Amended – 2015/07/20 – US$ 999.00
Hospitals' Credit Diagnosis (Tapering ACA Benefit Belies Decent Operating Fundamentals) – 2015/08/31 – US$ 999.00
U.S. Healthcare Recovery Tool (Second-Quarter 2015) – 2015/09/29 – US$ 300.00
U.S. Healthcare Recovery Tool (Third Quarter 2015) – 2015/12/15 – US$ 999.00
Fitch Publishes Capital Structure & Covenant Analysis for 50 Largest U.S. Leveraged Issuers – 2015/07/15 – US$ 149.00
Fitch Affirms Community Health Systems' at 'B+'; Outlook Revised to Stable – 2015/08/04 – US$ 149.00
Fitch: US Hospitals See Tapering Benefit of the ACA – 2015/08/31 – US$ 149.00
Fitch Updates Recovery Analyses for U.S. For-Profit Hospital Operators – 2015/09/29 – US$ 149.00
Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.
Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.
Search all our Credit Research from one place.